Schedule 13G ownership disclosure

MARINUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 56854Q200

Event date: 2024-04-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-052100
Form type
SC 13G
Filer
CITADEL ADVISORS LLC
CIK
CIK 1423053
Filed
Apr 25, 2024
Reporting period
Apr 15, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub